Review of: "Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye"
Résumé
Potential competing interests: No potential competing interests to declare.1-Authors neglect references related to methods of determination of PVR ( Rubilotta et al. 2021), IPSS, Qol, Qmax, etc… 2-The sample size in this study is small to build a conclusion about the benefits of Rezum water vapor.3-The study lacks a normal group of volunteers.4-Total PSA is not an accurate marker to exclude the presence of prostate cancer.It is known that prostate cancer risk lies between 4-10 ng/ml, but there are many cases that have no cancer in this range, and oppositely, there are many cancer cases that occur for patients who have a total PSA less than 4.5-Free PSA: total PSA is more accurate.A ratio less than 25% is diagnostic for prostate cancer.Why did the authors not determine the ratio to be sure about the exclusion criteria?
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →